Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

NCT: NCT07543367 · RECRUITING

NCT IDNCT07543367
StatusRECRUITING
Start Date2026-04
Completion2029-12

Brief Summary

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

Frequently Asked Questions

What is INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study?

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study is a clinical trial registered under NCT07543367. Current status: RECRUITING.

What is the status of NCT07543367?

The current status of NCT07543367 (INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study) is: RECRUITING.

When did INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study start?

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study started on 2026-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑